Cargando…

Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine

A new generation of vaccines for the neglected tropical diseases (NTDs) have now advanced into clinical development, with the Na-GST-1/Alhydrogel Hookworm Vaccine already being tested in Phase 1 studies in healthy adults. The current manuscript focuses on the often overlooked critical aspects of NTD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brelsford, Jill B., Plieskatt, Jordan L., Yakovleva, Anna, Jariwala, Amar, Keegan, Brian P., Peng, Jin, Xia, Pengjun, Li, Guangzhao, Campbell, Doreen, Periago, Maria Victoria, Correa-Oliveira, Rodrigo, Bottazzi, Maria Elena, Hotez, Peter J., Diemert, David, Bethony, Jeffrey M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325600/ https://www.ncbi.nlm.nih.gov/pubmed/28192438 http://dx.doi.org/10.1371/journal.pntd.0005385

Ejemplares similares

Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults
por: Diemert, David J., et al.
Publicado: (2017)

Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults
por: Diemert, David J., et al.
Publicado: (2020)

Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine Development
por: Diemert, David, et al.
Publicado: (2018)

Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naïve adults
por: Diemert, David J., et al.
Publicado: (2022)

Potency testing for a recombinant protein vaccine early in clinical development: Lessons from the Schistosoma mansoni Tetraspanin 2 vaccine
por: Li, Guangzhao, et al.
Publicado: (2021)

The Human Hookworm Vaccine
por: Hotez, Peter J., et al.
Publicado: (2013)

Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon
por: Mouwenda, Yoanne D., et al.
Publicado: (2021)

An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection
por: Pearson, Mark S., et al.
Publicado: (2009)

Hookworm: “The Great Infection of Mankind”
por: Hotez, Peter J, et al.
Publicado: (2005)

Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon
por: Betouke Ongwe, Madeleine Eunice, et al.
Publicado: (2022)

Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate
por: Curti, Elena, et al.
Publicado: (2014)

Vaccination with Recombinant Aspartic Hemoglobinase Reduces Parasite Load and Blood Loss after Hookworm Infection in Dogs
por: Loukas, Alex, et al.
Publicado: (2005)

The Global Economic and Health Burden of Human Hookworm Infection
por: Bartsch, Sarah M., et al.
Publicado: (2016)

X-ray structures of Na-GST-1 and Na-GST-2 two glutathione s-transferase from the human hookworm Necator americanus
por: Asojo, Oluwatoyin A, et al.
Publicado: (2007)

The human hookworm vaccine: recent updates and prospects for success
por: Bottazzi, M.E.
Publicado: (2015)

The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates
por: Wei, Junfei, et al.
Publicado: (2016)

Health Education through Analogies: Preparation of a Community for Clinical Trials of a Vaccine against Hookworm in an Endemic Area of Brazil
por: Gazzinelli, Maria Flavia, et al.
Publicado: (2010)

The Right Tool for the Job: Detection of Soil-Transmitted Helminths in Areas Co-endemic for Other Helminths
por: Periago, Maria V., et al.
Publicado: (2015)

A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries
por: Diemert, David J., et al.
Publicado: (2017)

Fit for genomic and proteomic purposes: Sampling the fitness of nucleic acid and protein derivatives from formalin fixed paraffin embedded tissue
por: Yakovleva, Anna, et al.
Publicado: (2017)

Characterization of Competitive ELISA and Formulated Alhydrogel Competitive ELISA (FAcE) for Direct Quantification of Active Ingredients in GMMA-Based Vaccines
por: Rossi, Omar, et al.
Publicado: (2020)

Correction: Microproteinuria during Opisthorchis viverrini Infection: A Biomarker for Advanced Renal and Hepatobiliary Pathologies from Chronic Opisthorchiasis
por: Saichua, Prasert, et al.
Publicado: (2013)

Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths
por: Alexander, Neal, et al.
Publicado: (2011)

Human Schistosomiasis Vaccines as Next Generation Control Tools
por: Hotez, Peter J., et al.
Publicado: (2023)

Getting Closer to a Vaccine for Hookworm
Publicado: (2005)

Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine
por: Seid, Christopher A, et al.
Publicado: (2015)

Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
por: Roestenberg, Meta, et al.
Publicado: (2008)

Necator americanus and Helminth Co-Infections: Further Down-Modulation of Hookworm-Specific Type 1 Immune Responses
por: Geiger, Stefan Michael, et al.
Publicado: (2011)

Developing a low-cost and accessible COVID-19 vaccine for global health
por: Hotez, Peter J., et al.
Publicado: (2020)

Empowering Girls and Women through Hookworm Prevention
por: Hotez, Peter J.
Publicado: (2018)

A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area
por: Diemert, David J., et al.
Publicado: (2023)

The End of the Line for Hookworm? An Update on Vaccine Development
por: Devaney, Eileen
Publicado: (2005)

Impact on Malaria Parasite Multiplication Rates in Infected Volunteers of the Protein-in-Adjuvant Vaccine AMA1-C1/Alhydrogel+CPG 7909
por: Duncan, Christopher J. A., et al.
Publicado: (2011)

Global regulatory reforms to promote equitable vaccine access in the next pandemic
por: Mahoney, Richard, et al.
Publicado: (2023)

COVID-19 vaccine design: the Janus face of immune enhancement
por: Hotez, Peter J., et al.
Publicado: (2020)

Advancing a multivalent ‘Pan-anthelmintic’ vaccine against soil-transmitted nematode infections
por: Zhan, Bin, et al.
Publicado: (2014)

2257: Vaccine efficacy and immunogenicity of recombinant WAP and CAP-1 proteins in AKR mice
por: Briggs, Neima, et al.
Publicado: (2018)

Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
por: Mullen, Gregory E. D., et al.
Publicado: (2008)

Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel® in mice
por: Coelho, Camila H., et al.
Publicado: (2019)

“Running the Gauntlet”: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a “Call to Action”
por: Bottazzi, Maria Elena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gfp2lu3cou9jboq3r31trqns5j